Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency
- 1 July 2007
- journal article
- Published by Elsevier in Kidney International
- Vol. 72 (1) , 72-81
- https://doi.org/10.1038/sj.ki.5002268
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injuryKidney International, 2006
- Circadian Expression of Plasminogen Activator Inhibitor-1 in Angiotensin II Type 1a Receptor Knockout MiceClinical and Experimental Hypertension, 2005
- Norepinephrine-Induced Changes in Cardiac Transforming Growth Factor-β Isoform Expression Pattern of Female and Male RatsHypertension, 2004
- Reduction of Vascular Noradrenaline Sensitivity by AT 1 Antagonists Depends on Functional Sympathetic InnervationHypertension, 2004
- Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ N G -Nitro- l -Arginine Methyl Ester-Induced Myocardial InjuryCirculation, 2003
- Dual Inhibition of β-Adrenergic and Angiotensin II Receptors by a Single AntagonistCirculation, 2003
- ACE Inhibition Versus Angiotensin Type 1 Receptor AntagonismHypertension, 2002
- Norepinephrine Enhances Fibrosis Mediated by TGF-β in Cardiac FibroblastsHypertension, 2002
- Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Journal of Clinical Investigation, 1995
- Interaction of angiotensin with noradrenergic neuroeffector transmissionTrends in Pharmacological Sciences, 1987